BRAF Mutations in Canine Cancers.
Activating mutations of the BRAF gene lead to constitutive activation of the MAPK pathway. Although many human cancers carry the mutated BRAF gene, this mutation has not yet been characterized in canine cancers. As human and canine cancers share molecular abnormalities, we hypothesized that BRAF gen...
Main Authors: | Hiroyuki Mochizuki, Katherine Kennedy, Susan G Shapiro, Matthew Breen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4460039?pdf=render |
Similar Items
-
Comparative Aspects of BRAF Mutations in Canine Cancers
by: Hiroyuki Mochizuki, et al.
Published: (2015-08-01) -
Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma.
by: Hiroyuki Mochizuki, et al.
Published: (2015-01-01) -
Canine Histiocytic Malignancies—Challenges and Opportunities
by: Katherine Kennedy, et al.
Published: (2016-01-01) -
Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation: Short in-frame deletions in BRAF and MAP2K1 suggest alternative mechanisms for MAPK pathway disruption.
by: Rachael Thomas, et al.
Published: (2023-04-01) -
BRAF mutation in colorectal cancer: An update
by: Colombo Alfredo, et al.
Published: (2023-01-01)